These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 9302210

  • 1. Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar.
    Rasoamanana B, Leroy F, Boisier P, Rasolomaharo M, Buchy P, Carniel E, Chanteau S.
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):587-91. PubMed ID: 9302210
    [Abstract] [Full Text] [Related]

  • 2. Short report: Serodiagnosis of plague in humans and rats using a rapid test.
    Thullier P, Guglielmo V, Rajerison M, Chanteau S.
    Am J Trop Med Hyg; 2003 Oct; 69(4):450-1. PubMed ID: 14640508
    [Abstract] [Full Text] [Related]

  • 3. [Seroepidemiologic study of human plague in Madagascar].
    Leroy F.
    Ann Biol Clin (Paris); 1997 Oct; 55(4):332-6. PubMed ID: 9309233
    [Abstract] [Full Text] [Related]

  • 4. Short- and long-term humoral immune response against Yersinia pestis in plague patients, Madagascar.
    Andrianaivoarimanana V, Iharisoa AL, Rahalison L, Ralimanantsoa ML, Ratsitorahina M, Rakotonanahary RJL, Carniel E, Demeure C, Rajerison M.
    BMC Infect Dis; 2020 Nov 10; 20(1):822. PubMed ID: 33172393
    [Abstract] [Full Text] [Related]

  • 5. Early diagnosis of bubonic plague using F1 antigen capture ELISA assay and rapid immunogold dipstick.
    Chanteau S, Rahalison L, Ratsitorahina M, Mahafaly, Rasolomaharo M, Boisier P, O'Brien T, Aldrich J, Keleher A, Morgan C, Burans J.
    Int J Med Microbiol; 2000 Jul 10; 290(3):279-83. PubMed ID: 10959730
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of a standardized F1 capsular antigen capture ELISA test kit for the rapid diagnosis of plague.
    Splettstoesser WD, Rahalison L, Grunow R, Neubauer H, Chanteau S.
    FEMS Immunol Med Microbiol; 2004 Jun 01; 41(2):149-55. PubMed ID: 15145459
    [Abstract] [Full Text] [Related]

  • 8. Serodiagnosis of human plague by an anti-F1 capsular antigen specific IgG/IgM ELISA and immunoblot.
    Neubauer H, Rahalison L, Brooks TJ, Aleksic S, Chanteau S, Splettstösser WD.
    Epidemiol Infect; 2000 Dec 01; 125(3):593-7. PubMed ID: 11218210
    [Abstract] [Full Text] [Related]

  • 9. Serodiagnosis of human plague by a combination of immunomagnetic separation and flow cytometry.
    Splettstoesser WD, Grunow R, Rahalison L, Brooks TJ, Chanteau S, Neubauer H.
    Cytometry A; 2003 Jun 01; 53(2):88-96. PubMed ID: 12766970
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A Bead-Based Flow Cytometric Assay for Monitoring Yersinia pestis Exposure in Wildlife.
    Chandler JC, Baeten LA, Griffin DL, Gidlewski T, DeLiberto TJ, Petersen JM, Pappert R, Young JW, Bevins SN.
    J Clin Microbiol; 2018 Jul 01; 56(7):. PubMed ID: 29695520
    [Abstract] [Full Text] [Related]

  • 13. [Contribution towards plague diagnosis].
    de Almeida AM, de Souza GT, Santos S, Silva SC, Petribú Mde M, Haver Pde O, Aragão AI, Tavares C.
    Rev Soc Bras Med Trop; 2007 Jul 01; 40(1):53-5. PubMed ID: 17486254
    [Abstract] [Full Text] [Related]

  • 14. Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice.
    Little SF, Webster WM, Wilhelm H, Fisher D, Norris SL, Powell BS, Enama J, Adamovicz JJ.
    Vaccine; 2010 Jan 22; 28(4):934-9. PubMed ID: 19925906
    [Abstract] [Full Text] [Related]

  • 15. Diagnosis of bubonic plague by PCR in Madagascar under field conditions.
    Rahalison L, Vololonirina E, Ratsitorahina M, Chanteau S.
    J Clin Microbiol; 2000 Jan 22; 38(1):260-3. PubMed ID: 10618097
    [Abstract] [Full Text] [Related]

  • 16. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague.
    Chanteau S, Rahalison L, Ralafiarisoa L, Foulon J, Ratsitorahina M, Ratsifasoamanana L, Carniel E, Nato F.
    Lancet; 2003 Jan 18; 361(9353):211-6. PubMed ID: 12547544
    [Abstract] [Full Text] [Related]

  • 17. F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy.
    Chanteau S, Rabarijaona L, O'Brien T, Rahalison L, Hager J, Boisier P, Burans J, Rasolomaharo M.
    Trans R Soc Trop Med Hyg; 1998 Jan 18; 92(5):572-3. PubMed ID: 9861385
    [No Abstract] [Full Text] [Related]

  • 18. Seroepidemiology of human plague in the Madagascar highlands.
    Ratsitorahina M, Rabarijaona L, Chanteau S, Boisier P.
    Trop Med Int Health; 2000 Feb 18; 5(2):94-8. PubMed ID: 10747268
    [Abstract] [Full Text] [Related]

  • 19. Rapid and sensitive detection of Yersinia pestis by lateral-flow assay in simulated clinical samples.
    Hsu HL, Chuang CC, Liang CC, Chiao DJ, Wu HL, Wu YP, Lin FP, Shyu RH.
    BMC Infect Dis; 2018 Aug 14; 18(1):402. PubMed ID: 30107826
    [Abstract] [Full Text] [Related]

  • 20. Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.
    Anderson GW, Leary SE, Williamson ED, Titball RW, Welkos SL, Worsham PL, Friedlander AM.
    Infect Immun; 1996 Nov 14; 64(11):4580-5. PubMed ID: 8890210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.